Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT05481216 Completed - COVID-19 Clinical Trials

HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV

HIV CoCo
Start date: March 29, 2022
Phase:
Study type: Observational

HIV CoCo is a European multi-centre, multi-country, retrospective, observational case-control study that will aim to describe clinical outcomes and identify risk factors for People Living With HIV (PLWHIV) who are co-infected with the SARS-CoV-2 coronavirus. The study will address two central questions: 1. Is there a particular risk for COVID-19 in PLWHIV as compared to HIV seronegative control COVID-19 cases? 2. Are there particular factors, within the group of PLWHIV, which put them at risk for a more severe COVID-19 disease course? The study will address these questions by recruiting patients co-infected with both HIV and SARS-CoV-2 and comparing them to two control groups - one group infected with SARS-CoV-2 only and another group infected with HIV only. Only deidentified, real-world retrospective data will be used for the study, collected as part of standard, routine clinical care. Additionally, this study will also look to: 1. Describe the differences in the clinical manifestation of COVID-19 in PLWHIV compared to HIV seronegative controls 2. Describe the response to treatment, including supportive care and novel therapies against COVID-19, including antiviral or immunomodulatory therapy 3. Describe the co-morbidities in PLWHIV and controls with COVID-19 4. Compare the severity of COVID-19 between PLWHIV and the COVID-19 only controls at diagnosis and hospital admission. Data will be collected about patient outcomes from COVID-19 (including hospitalisation for COVID-19, length of stay in hospital, critical care admission, ventilation/oxygenation requirements, and need for kidney replacement therapy), as well as pre-existing health conditions, and relevant blood results at COVID-19 diagnosis.

NCT ID: NCT05481203 Completed - Anxiety Clinical Trials

The Effect Of Distraction Methods On Fear And Anxiety In Children Before The Covid 19 Test

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Aim: This research will be carried out to determine the effect of distracting methods on fear and anxiety in children before the COVID test.

NCT ID: NCT05481190 Completed - Quality of Life Clinical Trials

The Impact Of A Tele-Exercise Program For Children With Cystic Fibrosis During The Covid-19 Pandemic On Quality Of Life

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study was to examine the effect of the tele-exercise program applied to children with cystic fibrosis in the Covid-19 pandemic on the quality of life and the symptoms experienced during exercise

NCT ID: NCT05477394 Completed - COVID-19 Clinical Trials

Metabolic Syndrome as Prognostic Factor for Outcome of Sever SARS-COV-2 Cases.

COVID19
Start date: April 1, 2021
Phase:
Study type: Observational

SARS-COV-2 crisis is a severe public health concern in the world. It is now well recognized that older age, diabetes mellitus, obesity (BMI > 30 kg/m2), and hypertension increase the risk of complications and death in SARS-COV-2 patients. This study will describe the spectrum of clinical features, the likely pathophysiologic mechanisms, and potential implications for the management of metabolic syndrome in SARS-COV-2 patients.

NCT ID: NCT05477199 Completed - Clinical trials for Post-COVID-19 Syndrome

Physiotherapy in Post COVID-19 Syndrome Patients

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

Patients who have undergone COVID-19 infection often have long-term sequelae. One of the most prevalent sequelae is pain. The main objective of this research is to investigate the efficacy of a cognitive behavioral principles-based treatment program in fear avoidance beliefs, disability, pain catastrophizing and pain interference.

NCT ID: NCT05477186 Completed - COVID-19 Clinical Trials

Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

Start date: August 12, 2022
Phase: Phase 1
Study type: Interventional

Prevention of COVID-19 caused by SARS-CoV-2.

NCT ID: NCT05476848 Completed - COVID-19 Clinical Trials

Relationship Between Oral Findings and Salivary Factors in Sars-Cov-2 Patients

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Two hundred individuals will be formed according to the study and control groups: Group-1: coronavirus 2 (Covid-19) (+) patients (n=100) and Group-2: Healthy individuals (in which the volunteers will be included due to group-1) (n=100). Oral examinations including DMFT scores, salivary flow rate, visible gingival index scores and radiographs (OPG) will be performed on both groups on the 1st appointment. Oral swap samples will be collected with sterile swap brushes (Six sample for each person) on the 1st, 7th and 30th days to evaluate the salivary immunoglobulins (Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM)) and cytokine (IL-1, IL-6, IL-10) levels. Blood samples will be collected to validate the oral swap test results.

NCT ID: NCT05476835 Completed - Clinical trials for Post COVID-19 Condition

Effect of Pulmonary Rehabilitation Program on Post Hospitalization Severe COVID- 19 Patients

Start date: May 15, 2021
Phase: N/A
Study type: Interventional

COVID-19 infection was discovered to be the major global cause of a serious respiratory illness toward the end of 2019. The majority of COVID-19 patients experience mild disease, while about 14% go on to have severe disease and 6% end up in critical condition. An evidence-based standard of therapy called pulmonary rehabilitation includes exercise training, education, and behavior modification to help people with lung illness feel better physically and mentally. The aim of the study to evaluate the effect of pulmonary rehabilitation program on severe post covid19 patients (post hospitalization) regarding pulmonary function tests and dyspnea score.

NCT ID: NCT05476315 Completed - COVID-19 Clinical Trials

Emergency Surgery During Covid Compared to Emergency Surgery During Pre-covid Period

Start date: March 9, 2019
Phase:
Study type: Observational

The aim of this study is to analyze the trend of hospitalizations and how emergency operations have qualitatively and quantitatively changed in our Department of Medical and Surgical Sciences of the Foggia Hospital from 2019 (pre-covid era) to date.

NCT ID: NCT05476302 Completed - COVID-19 Clinical Trials

Effect of Remote Cognitive Intervention in Patients With Parkinson's Disease During the COVID-19 Pandemic

TELEPARK
Start date: January 1, 2020
Phase:
Study type: Observational

Retrospective study to evaluate the effect of a remote cognitive-rehabilitative intervention during the Covid outbreak in subjects with Parkinson's disease.